Consolidated Statement of Changes in Stockholders' Equity (Parenthetical) |
12 Months Ended |
|---|---|
|
Dec. 31, 2018
USD ($)
shares
| |
| Statement of Stockholders' Equity [Abstract] | |
| Common stock, shares exchanged | shares | 2,090,301 |
| Conversion of stock, costs | $ 82,502 |
| Issuance of common stock units for cash, cost | 308,830 |
| Issuance of common stock units for a clinical trial funding commitment, cost | $ 168,457 |
| X | ||||||||||
- Definition Conversion of stock, net of costs. No definition available.
|
| X | ||||||||||
- Definition Issuance of common stock units for a clinical trial funding commitment, cost. No definition available.
|
| X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cash outflow for cost incurred directly with the issuance of an equity security. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- References No definition available.
|